Catalyst Pharmaceuticals (CPRX) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.17% |
| Dec 31, 2025 | -48.02% |
| Sep 30, 2025 | -48.59% |
| Jun 30, 2025 | 14.33% |
| Mar 31, 2025 | -16.11% |
| Dec 31, 2024 | 12.88% |
| Sep 30, 2024 | 2.08% |
| Jun 30, 2024 | -62.22% |
| Mar 31, 2024 | 936.75% |
| Dec 31, 2023 | 128.82% |
| Sep 30, 2023 | -289.31% |
| Jun 30, 2023 | 120.34% |
| Mar 31, 2023 | -454.71% |
| Dec 31, 2022 | -6.25% |
| Sep 30, 2022 | 94.63% |
| Jun 30, 2022 | 234.91% |
| Mar 31, 2022 | -58.29% |
| Dec 31, 2021 | -15.00% |
| Sep 30, 2021 | 145.27% |
| Jun 30, 2021 | 373.87% |
| Mar 31, 2021 | -122.15% |
| Dec 31, 2020 | 539.29% |
| Sep 30, 2020 | -84.56% |
| Jun 30, 2020 | 8.68% |
| Mar 31, 2020 | -72.51% |
| Dec 31, 2019 | 106.48% |
| Sep 30, 2019 | 397.39% |
| Jun 30, 2019 | 71.90% |
| Mar 31, 2019 | -57.56% |
| Dec 31, 2018 | 715.94% |
| Sep 30, 2018 | 107.50% |
| Jun 30, 2018 | 74.37% |
| Mar 31, 2018 | -175.54% |
| Dec 31, 2017 | 4,098.25% |
| Sep 30, 2017 | 60.82% |
| Jun 30, 2017 | 18.13% |
| Mar 31, 2017 | -4.46% |
| Dec 31, 2016 | -247.08% |
| Sep 30, 2016 | 69.27% |
| Jun 30, 2016 | 41.55% |
| Mar 31, 2016 | -33.03% |
| Dec 31, 2015 | -0.99% |
| Sep 30, 2015 | -9.00% |
| Jun 30, 2015 | -112.73% |
| Mar 31, 2015 | 1,587.22% |
| Dec 31, 2014 | 38.75% |
| Sep 30, 2014 | -125.77% |
| Jun 30, 2014 | 1,300.63% |
| Mar 31, 2014 | 89.36% |
| Dec 31, 2013 | -188.94% |
| Sep 30, 2013 | 5,667.11% |
| Jun 30, 2013 | 127.43% |
| Mar 31, 2013 | 92.77% |
| Dec 31, 2012 | -336.91% |
| Sep 30, 2012 | 489.01% |
| Jun 30, 2012 | 12.25% |
| Mar 31, 2012 | -133.69% |
| Dec 31, 2011 | 409.06% |
| Sep 30, 2011 | 14.25% |
| Jun 30, 2011 | -204.69% |
| Mar 31, 2011 | 281.70% |
| Dec 31, 2010 | 5.90% |